Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban

Jonathan Douxfils, Anne Tamigniau, Jean-François Classen, Justine Baudar, Sébastien Walbrecq, Christian Chatelain, Bernard Chatelain, Pierre Wallemacq, François Mullier, Jean-Michel Dogne

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationJournal of Thrombosis and Haemostasis. 2013 Jul;11 Suppl 2:1-1322
Publication statusPublished - 2013
EventXXIV Congress of the International Society of Thrombosis and Haemostasis - Amsterdam, Netherlands
Duration: 29 Jun 20134 Jul 2013

Conference

ConferenceXXIV Congress of the International Society of Thrombosis and Haemostasis
CountryNetherlands
CityAmsterdam
Period29/06/134/07/13

Cite this

Douxfils, J., Tamigniau, A., Classen, J-F., Baudar, J., Walbrecq, S., Chatelain, C., ... Dogne, J-M. (2013). Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban. In Journal of Thrombosis and Haemostasis. 2013 Jul;11 Suppl 2:1-1322